Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Effect of probenecid on stroke recovery
FY 2013-14
Summary
The second leading cause of death worldwide is stroke. Stroke is the loss of brain function due to interrupted blood supply to the brain. This loss of function is the result of cells in the brain (neurons) dying due to a complex cascade of events caused by a loss of blood flow. Recently, key proteins have been identified that mediate this cascade, raising the possibility of new treatments for stroke that target these proteins and interrupt their role in the cascade. One such protein, known as pannexin 1, functions as a channel that connects the interior of cells to their outside environment. There is evidence that blocking this channel after a stroke has occurred leads to both smaller strokes and better regeneration of neurons after stroke.
Probenecid is a drug already approved for use in humans that has been shown to block pannexin 1. Therefore, our proposal aims to answer the question: Does treatment with probenecid after stroke result in improved stroke outcomes? We will answer this question by inducing stroke in mice in the part of the brain that controls the right forepaw, then determine the effect of probenecid on the ability of neurons to survive a stroke and regenerate after one. We will also analyze the effect of probenecid on the ability of the mice to use their right forepaw.
Every year stroke kills more than 14,000 Canadians, and costs the Canadian economy an estimated $3.6 billion. Research into new treatment options for stroke, particularly those that utilize drugs already approved for use in humans, such as probenecid, offer large and immediate potential benefits, and require relatively little cost up front.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311756
Name
Bell Scott
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effect of probenecid on stroke recovery
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Models; Differentiation; Drug Research; Ischemia; Neurogenesis; Pannexin; Photothrombosis; Probenecid; Rodent Behaviour; Stroke
Abstract
The second leading cause of death worldwide is stroke. Stroke is the loss of brain function due to interrupted blood supply to the brain. This loss of function is the result of cells in the brain (neurons) dying due to a complex cascade of events caused by a loss of blood flow. Recently, key proteins have been identified that mediate this cascade, raising the possibility of new treatments for stroke that target these proteins and interrupt their role in the cascade. One such protein, known as pannexin 1, functions as a channel that connects the interior of cells to their outside environment. There is evidence that blocking this channel after a stroke has occurred leads to both smaller strokes and better regeneration of neurons after stroke.
Probenecid is a drug already approved for use in humans that has been shown to block pannexin 1. Therefore, our proposal aims to answer the question: Does treatment with probenecid after stroke result in improved stroke outcomes? We will answer this question by inducing stroke in mice in the part of the brain that controls the right forepaw, then determine the effect of probenecid on the ability of neurons to survive a stroke and regenerate after one. We will also analyze the effect of probenecid on the ability of the mice to use their right forepaw.
Every year stroke kills more than 14,000 Canadians, and costs the Canadian economy an estimated $3.6 billion. Research into new treatment options for stroke, particularly those that utilize drugs already approved for use in humans, such as probenecid, offer large and immediate potential benefits, and require relatively little cost up front.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bell, Scott
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~